16.81
Abrdn Life Sciences Investors stock is traded at $16.81, with a volume of 210.67K.
It is down -0.18% in the last 24 hours and down -0.06% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$16.84
Open:
$16.51
24h Volume:
210.67K
Relative Volume:
1.14
Market Cap:
$485.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.94%
1M Performance:
-0.06%
6M Performance:
+33.94%
1Y Performance:
+21.55%
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQL
Abrdn Life Sciences Investors
|
16.81 | 486.21M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.13 | 3.76B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
36.30 | 3.25B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
22.79 | 2.79B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
14.98 | 2.35B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
26.40 | 2.32B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Abrdn Life Sciences Investors To Go Ex-Dividend On November 21st, 2025 With 0.5 USD Dividend Per Share - 富途牛牛
Why Abrdn Life Sciences Investors stock is a value investor pickJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
abrdn Healthcare Investors $HQH Stake Raised by Allworth Financial LP - Defense World
Is abrdn Life Sciences Investors Shares stock expanding market penetrationDay Trade & Technical Pattern Based Signals - newser.com
How abrdn Life Sciences Investors Shares stock stacks up against competitorsMarket Volume Report & Detailed Earnings Play Strategies - newser.com
Abrdn Life Sciences Investors Q3 2025 Commentary (NYSE:HQL) - Seeking Alpha
Can Abrdn Life Sciences Investors stock withstand economic slowdownJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
How institutional buying supports Abrdn Life Sciences Investors stockMarket Activity Recap & Entry Point Confirmation Signals - newser.com
What institutional flow reveals about Abrdn Life Sciences InvestorsPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Key resistance and support levels for Abrdn Life Sciences Investors2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
Reversal indicators forming on Abrdn Healthcare Investors stockMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can abrdn Life Sciences Investors Shares stock ride next bull market cycle2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
Custom strategy builders for tracking Abrdn Life Sciences InvestorsEarnings Miss & Consistent Profit Trading Strategies - newser.com
Is Abrdn Life Sciences Investors stock ready for a breakoutJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Does Abrdn Life Sciences Investors show high probability of rebound - newser.com
Will abrdn Life Sciences Investors Shares stock draw ESG focused fundsPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is now a turning point for Abrdn Healthcare InvestorsCEO Change & Consistent Growth Equity Picks - newser.com
Why abrdn Life Sciences Investors Shares stock could rally stronglyMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
Is Abrdn Healthcare Investors stock overvalued by current metricsQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Will abrdn Healthcare Investors Shares of stock maintain strong growth2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
What analysts say about Abrdn Life Sciences Investors stockFederal Reserve Announcements & Rapid Portfolio Expansion - earlytimes.in
What earnings revisions data tells us about Abrdn Life Sciences InvestorsProduct Launch & Daily Entry Point Alerts - newser.com
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):